Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Galer

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Pain|February 8, 2005
Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain ScaleMark P Jensen, Robert H Dworkin, Arnold R Gammaitoni, et al.
The Journal of Pain|November 1, 2006
The pain quality assessment scale: assessment of pain quality in carpal tunnel syndromeMark P Jensen, Arnold R Gammaitoni, David O Olaleye, et al.
International Journal of Molecular Sciences|August 27, 2021
An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic EncephalopathiesParthena Martin, Thadd Reeder, Jo Sourbron, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|May 31, 2022
Long-term cardiovascular safety of fenfluramine in patients with Dravet syndrome treated for up to 3 years: Findings from serial echocardiographic assessmentsAnupam Agarwal, Gail M Farfel, Arnold R Gammaitoni, et al.
The Journal of Pain|September 1, 2006
Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning?Mark P Jensen, Robert H Dworkin, Arnold R Gammaitoni, et al.
The Journal of Pain|March 10, 2010
The assessment of pain quality: an item response theory analysisClare Waterman, Timothy W Victor, Mark P Jensen, et al.
Epilepsia|August 19, 2020
Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension studyWyman W Lai, Bradley S Galer, Pierre C Wong, et al.
The Clinical Journal of Pain|June 25, 2008
The dimensions of pain quality: factor analysis of the Pain Quality Assessment ScaleTimothy W Victor, Mark P Jensen, Arnold R Gammaitoni, et al.
The Clinical Journal of Pain|April 1, 2009
The pain quality response profile of oxymorphone extended release in the treatment of low back painErrol M Gould, Mark P Jensen, Timothy W Victor, et al.
European Journal of Neurology|October 30, 2016
Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patientsA Schoonjans, B P Paelinck, F Marchau, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Pain|February 8, 2005
Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain ScaleMark P Jensen, Robert H Dworkin, Arnold R Gammaitoni, et al.
The Journal of Pain|November 1, 2006
The pain quality assessment scale: assessment of pain quality in carpal tunnel syndromeMark P Jensen, Arnold R Gammaitoni, David O Olaleye, et al.
International Journal of Molecular Sciences|August 27, 2021
An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic EncephalopathiesParthena Martin, Thadd Reeder, Jo Sourbron, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|May 31, 2022
Long-term cardiovascular safety of fenfluramine in patients with Dravet syndrome treated for up to 3 years: Findings from serial echocardiographic assessmentsAnupam Agarwal, Gail M Farfel, Arnold R Gammaitoni, et al.
The Journal of Pain|September 1, 2006
Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning?Mark P Jensen, Robert H Dworkin, Arnold R Gammaitoni, et al.
The Journal of Pain|March 10, 2010
The assessment of pain quality: an item response theory analysisClare Waterman, Timothy W Victor, Mark P Jensen, et al.
Epilepsia|August 19, 2020
Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension studyWyman W Lai, Bradley S Galer, Pierre C Wong, et al.
The Clinical Journal of Pain|June 25, 2008
The dimensions of pain quality: factor analysis of the Pain Quality Assessment ScaleTimothy W Victor, Mark P Jensen, Arnold R Gammaitoni, et al.
The Clinical Journal of Pain|April 1, 2009
The pain quality response profile of oxymorphone extended release in the treatment of low back painErrol M Gould, Mark P Jensen, Timothy W Victor, et al.
European Journal of Neurology|October 30, 2016
Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patientsA Schoonjans, B P Paelinck, F Marchau, et al.
Pageof 13